BioSig Technologies, Inc. (BSGM)
NASDAQ: BSGM · Real-Time Price · USD
1.340
+0.040 (3.08%)
At close: Dec 20, 2024, 4:00 PM
1.300
-0.040 (-2.99%)
After-hours: Dec 20, 2024, 7:59 PM EST
BioSig Technologies Revenue
BioSig Technologies had revenue of $39.00K in the twelve months ending September 30, 2024, down -72.34% year-over-year. In the year 2023, BioSig Technologies had annual revenue of $18.00K, down -93.71%.
Revenue (ttm)
$39.00K
Revenue Growth
-72.34%
P/S Ratio
n/a
Revenue / Employee
$9,750
Employees
4
Market Cap
23.09M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Equillium | 45.91M |
DarioHealth | 23.05M |
Vivos Therapeutics | 14.58M |
Pulmatrix | 10.01M |
VSee Health | 8.06M |
NeurAxis | 2.46M |
iBio, Inc. | 175.00K |
BSGM News
- 5 weeks ago - BioSig Regains Compliance with Nasdaq's Minimum Bid Price Requirement - GlobeNewsWire
- 2 months ago - BioSig Technologies' Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel - GlobeNewsWire
- 5 months ago - BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation - GlobeNewsWire
- 5 months ago - BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024 - GlobeNewsWire
- 6 months ago - BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer - GlobeNewsWire
- 7 months ago - BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 7 months ago - BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders - GlobeNewsWire
- 8 months ago - BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent - GlobeNewsWire